These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 12740151

  • 1. Comparison of recombinant human luteinising hormone (r-hLH) and human menopausal gonadotropin (hMG) in assisted reproductive technology.
    Baer G, Loumaye E.
    Curr Med Res Opin; 2003; 19(2):83-8. PubMed ID: 12740151
    [Abstract] [Full Text] [Related]

  • 2. Recombinant gonadotropins.
    Lathi RB, Milki AA.
    Curr Womens Health Rep; 2001 Oct; 1(2):157-63. PubMed ID: 12112963
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effects of recombinant LH treatment on folliculogenesis and responsiveness to FSH stimulation.
    Durnerin CI, Erb K, Fleming R, Hillier H, Hillier SG, Howles CM, Hugues JN, Lass A, Lyall H, Rasmussen P, Thong J, Traynor I, Westergaard L, Yates R, Luveris Pretreatment Group.
    Hum Reprod; 2008 Feb; 23(2):421-6. PubMed ID: 18084048
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The serum follicle-stimulating hormone-to-luteinizing hormone ratio at the start of stimulation with gonadotropins after pituitary down-regulation is inversely correlated with a mature oocyte yield and can predict "low responders".
    Ho JY, Guu HF, Yi YC, Chen MJ, Ho ES.
    Fertil Steril; 2005 Apr; 83(4):883-8. PubMed ID: 15820795
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Recombinant human LH supplementation versus supplementation with urinary hCG-based LH activity during controlled ovarian stimulation in the long GnRH-agonist protocol: a matched case-control study.
    Bühler KF, Fischer R.
    Gynecol Endocrinol; 2012 May; 28(5):345-50. PubMed ID: 22115012
    [Abstract] [Full Text] [Related]

  • 9. The use of recombinant human LH (lutropin alfa) in the late stimulation phase of assisted reproduction cycles: a double-blind, randomized, prospective study.
    Tarlatzis B, Tavmergen E, Szamatowicz M, Barash A, Amit A, Levitas E, Shoham Z.
    Hum Reprod; 2006 Jan; 21(1):90-4. PubMed ID: 16172149
    [Abstract] [Full Text] [Related]

  • 10. Dosing Characteristics of Recombinant Human Luteinizing Hormone or Human Menopausal Gonadotrophin-Derived LH Activity in Patients Undergoing Ovarian Stimulation: A German Fertility Database Study.
    Strezsak V, Allignol A, Bühler K, Fischer R, Hubbard J, Longobardi S, Lispi M, Schertz J, Verpillat P.
    Gynecol Obstet Invest; 2023 Jan; 88(4):214-225. PubMed ID: 37369184
    [Abstract] [Full Text] [Related]

  • 11. Clinical effects of ovulation induction with recombinant follicle-stimulating hormone supplemented with recombinant luteinizing hormone or low-dose recombinant human chorionic gonadotropin in the midfollicular phase in microdose cycles in poor responders.
    Berkkanoglu M, Isikoglu M, Aydin D, Ozgur K.
    Fertil Steril; 2007 Sep; 88(3):665-9. PubMed ID: 17292895
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Gene expression profiles of cumulus cells obtained from women treated with recombinant human luteinizing hormone + recombinant human follicle-stimulating hormone or highly purified human menopausal gonadotropin versus recombinant human follicle-stimulating hormone alone.
    Gatta V, Tatone C, Ciriminna R, Vento M, Franchi S, d'Aurora M, Sperduti S, Cela V, Borzì P, Palermo R, Stuppia L, Artini PG.
    Fertil Steril; 2013 Jun; 99(7):2000-8.e1. PubMed ID: 23472943
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Controlled ovarian stimulation with exclusive FSH followed by stimulation with hCG alone, FSH alone or hMG.
    Gomes MK, Vieira CS, Moura MD, Manetta LA, Leite SP, Reis RM, Ferriani RA.
    Eur J Obstet Gynecol Reprod Biol; 2007 Jan; 130(1):99-106. PubMed ID: 16835006
    [Abstract] [Full Text] [Related]

  • 17. [Recent progress in the hormonal treatment of sterility].
    Fanard A.
    Brux Med; 1975 Jul; 55(7):401-14. PubMed ID: 1098749
    [Abstract] [Full Text] [Related]

  • 18. Contemporary pharmacological manipulation in assisted reproduction.
    Huirne JA, Lambalk CB, van Loenen AC, Schats R, Hompes PG, Fauser BC, Macklon NS.
    Drugs; 2004 Jul; 64(3):297-322. PubMed ID: 14871171
    [Abstract] [Full Text] [Related]

  • 19. Randomized trial to compare the effect of recombinant human FSH (follitropin alfa) with or without recombinant human LH in women undergoing assisted reproduction treatment.
    Marrs R, Meldrum D, Muasher S, Schoolcraft W, Werlin L, Kelly E.
    Reprod Biomed Online; 2004 Feb; 8(2):175-82. PubMed ID: 14989794
    [Abstract] [Full Text] [Related]

  • 20. Lower apoptosis rate in human cumulus cells after administration of recombinant luteinizing hormone to women undergoing ovarian stimulation for in vitro fertilization procedures.
    Ruvolo G, Bosco L, Pane A, Morici G, Cittadini E, Roccheri MC.
    Fertil Steril; 2007 Mar; 87(3):542-6. PubMed ID: 17126339
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.